title: Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
authors.forename: J
authors.initials: J
authors.lastname: Verdejo
authors.forename: J
authors.initials: J
authors.lastname: Alvar
authors.forename: R M
authors.initials: RM
authors.lastname: Polo
authors.forename: J M
authors.initials: JM
authors.lastname: González-Lahoz
mesh_terms: D000965:Antimony; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D007108:Immune Tolerance; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use*; D013012:Sorbitol / Q000031:analogs & derivatives*
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D013012:Sorbitol; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony